All stock lists
Unlock the score
Damora Therapeutics, Inc. (DMRA)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
21.34+0.25 (+1.19%)
Insider Score
Insider Score
/ 100
DMRA Insider Score
Damora Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
DMRA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 9.45 M | 7.03 M | 4.07 M | 1.74 M | 1.96 M | — |
| R&D Expense | 25.54 M | 23.78 M | 197.63 M | 1.42 M | 1.47 M | — |
| Operating Expenses | 34.99 M | 30.81 M | 201.70 M | 3.16 M | 3.42 M | — |
| Operating Income | -34.99 M | -30.81 M | -201.70 M | -3.16 M | -3.42 M | — |
| Pretax Income | -30.92 M | -27.74 M | -200.69 M | -3.13 M | -3.43 M | — |
| Tax Provision | 255.00 K | 42.00 K | 44.00 K | 0.00 | 4.00 K | — |
| Net Income | -31.17 M | -27.78 M | -200.74 M | -3.13 M | -3.44 M | — |
| EPS (Basic) | -0.39 | -0.62 | — | -2.36 | -2.60 | -1.92 |
| EPS (Diluted) | -0.39 | -0.62 | — | -2.36 | -2.60 | -1.92 |
| Shares Outstanding | 61.12 M | 34.30 M | — | 1.33 M | 1.32 M | 1.32 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.